DK270990A - Anvendelse af injicerbare mikrokugler indeholdende en copolymer, fremgangsmaade til deres fremstilling samt suspensioner med indhold deraf - Google Patents

Anvendelse af injicerbare mikrokugler indeholdende en copolymer, fremgangsmaade til deres fremstilling samt suspensioner med indhold deraf Download PDF

Info

Publication number
DK270990A
DK270990A DK270990A DK270990A DK270990A DK 270990 A DK270990 A DK 270990A DK 270990 A DK270990 A DK 270990A DK 270990 A DK270990 A DK 270990A DK 270990 A DK270990 A DK 270990A
Authority
DK
Denmark
Prior art keywords
microgouls
injectable
suspensions
copolymer
contents
Prior art date
Application number
DK270990A
Other languages
Danish (da)
English (en)
Other versions
DK270990D0 (da
Inventor
Gerard Cohen
Jean-Luc Dubois
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of DK270990D0 publication Critical patent/DK270990D0/da
Publication of DK270990A publication Critical patent/DK270990A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK270990A 1989-11-15 1990-11-13 Anvendelse af injicerbare mikrokugler indeholdende en copolymer, fremgangsmaade til deres fremstilling samt suspensioner med indhold deraf DK270990A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR898914976A FR2654337B1 (fr) 1989-11-15 1989-11-15 Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.

Publications (2)

Publication Number Publication Date
DK270990D0 DK270990D0 (da) 1990-11-13
DK270990A true DK270990A (da) 1991-05-16

Family

ID=9387417

Family Applications (1)

Application Number Title Priority Date Filing Date
DK270990A DK270990A (da) 1989-11-15 1990-11-13 Anvendelse af injicerbare mikrokugler indeholdende en copolymer, fremgangsmaade til deres fremstilling samt suspensioner med indhold deraf

Country Status (13)

Country Link
JP (1) JPH03294229A (de)
AT (1) AT400298B (de)
BE (1) BE1005511A4 (de)
CA (1) CA2029940A1 (de)
CH (1) CH681691A5 (de)
DE (1) DE4036425A1 (de)
DK (1) DK270990A (de)
FR (1) FR2654337B1 (de)
GB (1) GB2239798B (de)
IT (1) IT1242010B (de)
LU (1) LU87836A1 (de)
NL (1) NL9002492A (de)
SE (1) SE9003570L (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
HU222501B1 (hu) * 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
ES2105525T3 (es) * 1993-06-24 1997-10-16 Lilly Co Eli 2-fenil-3-aroilbenzotiofenos antiestrogenicos como agentes hipoglicemicos.
US5910492A (en) * 1995-06-05 1999-06-08 Takeda Chemical Industries, Ltd. Osteogenic promoting pharmaceutical composition
EP2210585A1 (de) 2009-01-16 2010-07-28 Exelgyn Pharmazeutische SPRM-Zusammensetzungen, Behandlungsverfahren unter Anwendung dieser

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4293539A (en) * 1979-09-12 1981-10-06 Eli Lilly And Company Controlled release formulations and method of treatment
US4389330A (en) * 1980-10-06 1983-06-21 Stolle Research And Development Corporation Microencapsulation process
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2528434B1 (fr) * 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
US4530840A (en) * 1982-07-29 1985-07-23 The Stolle Research And Development Corporation Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
FR2537980B1 (fr) * 1982-12-17 1986-12-19 Sandoz Sa Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation
ES8502612A1 (es) * 1983-06-15 1985-02-01 Schering Ag Procedimiento para la preparacion de 13a-alquilgonanos
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
DE3347126A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
FR2566779B2 (fr) * 1984-06-29 1987-03-06 Roussel Uclaf Nouveaux derives steroides substitues en 11b, leur procede de preparation et leur application comme medicaments
CA1256638A (en) * 1984-07-06 1989-06-27 Motoaki Tanaka Polymer and its production
FR2573657B1 (fr) * 1984-11-29 1989-05-12 Roussel Uclaf Produit comprenant une substance antiprogestomimetique et une substance uterotonique
DE3533175A1 (de) * 1985-09-13 1987-03-19 Schering Ag Antigestagene zur verschiebung der endometrialen reifung
FR2596395B1 (fr) * 1986-03-26 1989-05-26 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
US4758435A (en) * 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
DE3633244A1 (de) * 1986-09-26 1988-03-31 Schering Ag Antigestagene zur hemmung der uterinen prostaglandinsynthese
EP0310542B1 (de) * 1987-10-01 1994-06-08 Schering Aktiengesellschaft Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren
DE3733478A1 (de) * 1987-10-01 1989-04-13 Schering Ag Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
DE3744054A1 (de) * 1987-12-21 1989-06-29 Schering Ag Verwendung von antigestagenen zur herstellung von arzneimitteln
JP2785023B2 (ja) * 1987-12-30 1998-08-13 ルセル―ユクラフ １７α位置を置換された１７β―ＯＨ―１９―ノルステロイドの新誘導体、その製造方法、その薬剤としての使用及びそれを含有する製薬組成物
JP2670680B2 (ja) * 1988-02-24 1997-10-29 株式会社ビーエムジー 生理活性物質含有ポリ乳酸系微小球およびその製造法

Also Published As

Publication number Publication date
CA2029940A1 (fr) 1991-05-16
FR2654337B1 (fr) 1994-08-05
DK270990D0 (da) 1990-11-13
NL9002492A (nl) 1991-06-03
IT1242010B (it) 1994-02-02
LU87836A1 (fr) 1991-05-07
IT9048470A1 (it) 1992-05-13
ATA231390A (de) 1995-04-15
AT400298B (de) 1995-11-27
IT9048470A0 (it) 1990-11-13
SE9003570D0 (sv) 1990-11-09
CH681691A5 (de) 1993-05-14
GB9024862D0 (en) 1991-01-02
FR2654337A1 (fr) 1991-05-17
JPH03294229A (ja) 1991-12-25
GB2239798B (en) 1993-10-27
BE1005511A4 (fr) 1993-08-31
GB2239798A (en) 1991-07-17
SE9003570L (sv) 1991-05-16
DE4036425A1 (de) 1991-05-16

Similar Documents

Publication Publication Date Title
DK316189A (da) Heteroaryloxy-n-isopropylanilider, fremgangsmaade til deres fremstilling samt deres anvendelse
DK594885D0 (da) 2-(2'-nitrobenzoyl)-1,3-cyklohexandioner, fremgangsmaade til fremstilling deraf, deres anvendelse samt midler indeholdende dem
DK37089A (da) Quinazolinderivater, fremgangsmaader til deres fremstilling samt deres anvendelse
DK286786A (da) Hydrogeldannende polymersammensaetning, fremgangsmaade til fremstilling af samme samt absorberende struktur og artikel indeholdendesammensaetningen
DK594685D0 (da) 2-(2'-alkylbenzoyl)-1,3-cyklohexandioner, fremgangsmaade til fremstilling deraf, deres anvendelse samt midler indeholdende dem
DK85087A (da) Substituerede thienoimidazol-derivater, deres fremstilling, praeparater, indeholdende disse, samt anvendelse deraf
DK441489D0 (da) Fremgangsmaade til overfoersel af faste, naesten vandfrie affaldsstoffer til glasform samt anlaeg til udoevelse af fremgangsmaaden
DK110289A (da) Fremgangsmaade til fremstilling af cycliske sulfater
DK162054C (da) Cephalosporinsalte, fremgangsmaade til fremstilling deraf samt injicerbare praeparater indeholdende samme
DK403287D0 (da) 1,4-dihydropyridinderivater med calciumagonist- og alfa1-antagonist-virkning samt fremgangsmaader til deres fremstilling
DK270990D0 (da) Anvendelse af injicerbare mikrokugler indeholdende en copolymer, fremgangsmaade til deres fremstilling samt suspensioner med indhold deraf
DK114189D0 (da) Benzocycloheptenderivater, samt laegemidler med indhold af saadanne forbindelser
DK476685A (da) Alfa-aminoalkyl-alfa-alkylphenylacetonitrilderivater, fremgangsmaade til fremstilling af samme samt farmaceutisk komposition med indhold heraf
DK178589D0 (da) Triazoloaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK19489D0 (da) Fremgangsmaade til stabilisering af cephalosporinderivater samt stabile praeparater med cephalosporinderivater
DE69008406D1 (de) N-Hydroxycarbyloxy-Derivate von s-Triazinen mit gehinderter Aminogruppe.
DK303589A (da) 19-nor-progesteronderivater, deres fremstilling samt laegemidler med indhold deraf
DK380787D0 (da) Decahydro-2-naphthylalkylaminer, fremgangsmaade til deres fremstilling samt deres anvendelse
DK259089D0 (da) Aminoguanidinoaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK630788D0 (da) N-substituerede dichlormaleinimider, fremgangsmaade til deres fremstiling samt deres anvendelse
DK378989D0 (da) Halogenvinylazolderivater, fremgangsmaader til deres fremstilling samt deres anvendelse
DK208689A (da) 3-cyano-4-phenyl-pyrrolderivater, fremgangsmaade til deres fremstilling samt deres anvendelse
DK425587A (da) Fremgangsmaade til fremstilling af et praeparat af prothrombin-fattige, vitamin k-afhaengige stoerkningsfaktorer samt laegemiddel indeholdende dette
DK63089A (da) 1-aminomethyl-3-(2,4-diflour-3-chlorphenyl)-4-cyanopyrroler, fremgangsmaader til deres fremstilling samt deres anvendelse
DK467089D0 (da) Hyldeside, anvendelse heraf, samt fremgangsmaade til fremstilling af en hyldeside

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment